FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 1,665,775	$ 1,523,467
Gross Unrealized Gains	15	719
Gross Unrealized Losses	(19,720)	(2,518)
Aggregate Fair Value	1,646,070	1,521,668
Cash and Cash Equivalents	761,515	587,276	[1]
Short-term Marketable Securities	512,253	426,599	[1]
Long-term Marketable Securities	372,302	507,793	[1]
Level 1: | Cash
Schedule of Available-for-sale Securities [Line Items]
Cash	358,325	301,177
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Aggregate Fair Value	358,325	301,177
Cash and Cash Equivalents	358,325	301,177
Short-term Marketable Securities	0	0
Long-term Marketable Securities	0	0
Level 2:
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,307,450	1,222,290
Gross Unrealized Gains	15	719
Gross Unrealized Losses	(19,720)	(2,518)
Aggregate Fair Value	1,287,745	1,220,491
Cash and Cash Equivalents	403,190	286,099
Short-term Marketable Securities	512,253	426,599
Long-term Marketable Securities	372,302	507,793
Level 2: | Money market instruments
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	347,274	285,099
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Aggregate Fair Value	347,274	285,099
Cash and Cash Equivalents	347,274	285,099
Short-term Marketable Securities	0	0
Long-term Marketable Securities	0	0
Level 2: | Corporate debt securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	522,723	584,000
Gross Unrealized Gains	10	386
Gross Unrealized Losses	(14,622)	(2,086)
Aggregate Fair Value	508,111	582,300
Cash and Cash Equivalents	978	0
Short-term Marketable Securities	273,333	200,304
Long-term Marketable Securities	233,800	381,996
Level 2: | U.S. government agency securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	354,810	224,774
Gross Unrealized Gains	4	182
Gross Unrealized Losses	(4,377)	(325)
Aggregate Fair Value	350,437	224,631
Cash and Cash Equivalents	54,938	0
Short-term Marketable Securities	209,469	146,421
Long-term Marketable Securities	86,030	78,210
Level 2: | Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	29,461	68,384
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(22)	0
Aggregate Fair Value	29,440	68,384
Cash and Cash Equivalents	0	1,000
Short-term Marketable Securities	29,440	67,384
Long-term Marketable Securities	0	0
Level 2: | Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	53,182	56,936
Gross Unrealized Gains	0	10
Gross Unrealized Losses	(699)	(95)
Aggregate Fair Value	52,483	56,851
Cash and Cash Equivalents	0	0
Short-term Marketable Securities	11	9,451
Long-term Marketable Securities	$ 52,472	47,400
Level 2: | Foreign and other
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost		3,097
Gross Unrealized Gains		141
Gross Unrealized Losses		(12)
Aggregate Fair Value		3,226
Cash and Cash Equivalents		0
Short-term Marketable Securities		3,039
Long-term Marketable Securities		$ 187
Minimum
Schedule of Available-for-sale Securities [Line Items]
Long term marketable securities maturity period	1 year	1 year
Maximum
Schedule of Available-for-sale Securities [Line Items]
Short term marketable securities maturity period	1 year	1 year
Long term marketable securities maturity period	5 years	5 years

[1] (1)Certain December 31, 2021 balances have been corrected for an immaterial error identified in the third quarter of 2022. See Note 1 to these Condensed Consolidated Financial Statements for details.